Legal news - Health and pharma
- Agathe Lemaire
- Armelle Mongodin
- Benoît LAFOURCADE
- Brice Wartel
- Charlie Barbier
- Corentin BOUTIGNON
- Clément Pétrolli
- France Baumert
- Fabrice DELOUIS
- Frédéric Gorce
- Faustine Quillé
- Gabriel Aouizerat
- Isabelle GAVANON
- Julien Delory
- Jean-Philippe Chenard
- Julie Piquet
- Julie Da Vara
- Kevin POUJOL
- Johanna SCHWARTZ MIRALLES
- Maïté Lavrilleux-Carboni
- Mûre Maestrati
- Pierre-Antoine DUBECQ
- Sophie COIGNAT
- Competition and distribution
- Corporate law
- Employment law
- Firm news
- Health and pharma
- Insolvency and restructuring
- Insurance law
- Intellectual property and new technologies
- International law
- IT and Data
- Litigation
- Non classé
- Property and construction
- Public and environmental law
- Securities law
- Tax law
- Vineyard and wine law
Read +
Corporate lawEmployment lawFirm newsHealth and pharmaInternational law
DELCADE advises Geistlich Pharma AG on taking control of OST Développement
The European regenerative medicine market continues to consolidate. On 24 April 2026, the Swiss group Geistlich Pharma AG completed the acquisition of a majority stake in OST Développement, a French specialist in bone regeneration. DELCADE acted as legal counsel to the acquirer, extending a collaboration that began back in 2024. A two-stage M&A move The […]
Read